Dynavax Technologies

1 Follower


At Dynavax we are proud of work we do. Through our expertise in TLR biology we have designed compounds that stimulate multiple innate mechanisms of tumor and development of immune memory associated with tumor-specific antigens.

David Novack
President & COO
Jeff Coon
SVP of HR & Administration
Michael S. Ostrach
SVP, CFO & Chief Business Officer
Robert Janssen
Chief Medical Officer & SVP of Clinical Development
Steven N. Gersten
SVP, General Counsel, Chief Ethics & Compliance Officer & Secretary
Donn Casale
SVP of Commercial
Dong Yu
SVP of Vaccine Research
Meg Smith
VP of Sales & Operations
Eric Frings
VP of Site Head & Managing Director
Todd Lopeman
VP of Technical Operations

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.